Home538965 • BOM
add
Concord Drugs Ltd
Previous close
₹53.10
Day range
₹52.04 - ₹53.00
Year range
₹26.10 - ₹67.00
Market cap
520.40M INR
Avg Volume
40.09K
P/E ratio
153.06
Dividend yield
-
Primary exchange
BOM
Market news
NFLX
0.68%
0.29%
Financials
Income Statement
Revenue
Net income
(INR) | Jun 2025info | Y/Y change |
---|---|---|
Revenue | 136.06M | 16.36% |
Operating expense | 15.39M | -29.32% |
Net income | 1.18M | 331.14% |
Net profit margin | 0.86 | 273.91% |
Earnings per share | — | — |
EBITDA | 10.06M | 14.01% |
Effective tax rate | 25.69% | — |
Balance Sheet
Total assets
Total liabilities
(INR) | Jun 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 2.25M | 27.78% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 341.14M | — |
Shares outstanding | 9.81M | — |
Price to book | 1.51 | — |
Return on assets | — | — |
Return on capital | 3.04% | — |
Cash Flow
Net change in cash
(INR) | Jun 2025info | Y/Y change |
---|---|---|
Net income | 1.18M | 331.14% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
1995
Website
Employees
185